Loading…
Veronvy was cited for marketing unapproved new drugs "Elily Veronvy" and "Elily Veronvy 40+" in violation of the Federal Food, Drug, and Cosmetic Act. The company made drug claims on its website including assertions that the products helped people lose up to 52 pounds in three months, suppressed appetite, slowed gastric emptying, and accelerated metabolism for weight loss—while falsely claiming FDA approval. The products violated sections 505(a) and 301(d) of the FD&C Act as unapproved new drugs and section 502 as misbranded drugs.